EUVIMEDEUVIMED entdecken
Crossref

COMPARATIVE POSTMARKETING ANALYSIS OF ANAPHYLAXIS WITH RESPIRATORY BIOLOGICS USING THE FDA ADVERSE EVENT REPORTING SYSTEM

J. Priessnitz, J. Han, K. Lam

Annals of Allergy, Asthma & Immunology · 2026-11 · 137 (5) · S3

DOI: 10.1016/j.anai.2026.09.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Allergy, Asthma & Immunology, 2026-11. Verfasst von J. Priessnitz und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Priessnitz, J., Han, J., & Lam, K. (2026). COMPARATIVE POSTMARKETING ANALYSIS OF ANAPHYLAXIS WITH RESPIRATORY BIOLOGICS USING THE FDA ADVERSE EVENT REPORTING SYSTEM. Annals of Allergy, Asthma & Immunology, 137(5), S3. https://doi.org/10.1016/j.anai.2026.09.005

Vancouver

Priessnitz J, Han J, Lam K. COMPARATIVE POSTMARKETING ANALYSIS OF ANAPHYLAXIS WITH RESPIRATORY BIOLOGICS USING THE FDA ADVERSE EVENT REPORTING SYSTEM. Annals of Allergy, Asthma & Immunology. 2026;137(5):S3. doi:10.1016/j.anai.2026.09.005

BibTeX
@article{Priessnitz2026,
  author = {Priessnitz, J. and Han, J. and Lam, K.},
  title = {COMPARATIVE POSTMARKETING ANALYSIS OF ANAPHYLAXIS WITH RESPIRATORY BIOLOGICS USING THE FDA ADVERSE EVENT REPORTING SYSTEM},
  journal = {Annals of Allergy, Asthma & Immunology},
  year = {2026},
  volume = {137},
  number = {5},
  pages = {S3},
  doi = {10.1016/j.anai.2026.09.005}
}
Kostenlos starten →